This is the authors' abstract. We don't add key points for this paper.
Objective Indirubin (IND), a natural antitumor alkaloid, exhibits poor solubility, low bioavailability, and non-specific toxicity, limiting its clinical application against lung cancer. This study aimed to construct a polyethylene glycol (PEG)-functionalized single-walled carbon nanotube (SWCNT)-based nanoplatform (IND/SW-PEG) and evaluate its anti-lung cancer efficacy. Methods IND/SW-PEG was prepared via non-covalent adsorption and PEG surface modification. Drug loading efficiency, physicochemical properties, and pH-responsive drug release were characterized. Cytotoxicity, photothermal effect, and apoptosis induction were evaluated in A549 lung cancer cells and TC-1 normal lung epithelial cells using CCK-8 assay and flow cytometry. Results The optimal SWCNT-to-IND mass ratio was 1:1, yielding a drug loading efficiency of 25.7%. IND/SW-PEG exhibited significantly higher cumulative drug release at pH 5.0 (mimicking tumor microenvironment) than at pH 7.4. The IC 50 value of IND/SW-PEG against A549 cells was 98.2 μg/mL, equivalent to 76.56 μM indirubin. Combined with 808 nm near-infrared light irradiation, its anticancer potency was further improved, and concentration-dependent cell apoptosis was verified experimentally. Conclusion The IND/SW-PEG nanoplatform integrates chemotherapy and photothermal therapy, showing selective cytotoxicity, pH-responsive drug release, and potential to overcome current limitations of indirubin-based lung cancer treatment. Further in vivo studies are warranted to support clinical translation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: